Add BrightSurf on Google Email

Combining immunotherapies against cancer

Researchers developed a microparticle-based cancer vaccine that kickstarts an immune response, increasing the proportion of mice cured of tumors to 75%. Combining the vaccine with immune checkpoint inhibitors greatly improves treatment success, offering a promising approach to improving cancer treatment.

SourceUniversity of Konstanz·JournalNature Communications·DateMay 18, 2021

Scientists rewrite the genesis of mosquito-borne viruses

Researchers have discovered a misinterpreted model of immature flavivirus particles, revealing an unexpected organisation that could lead to new and better vaccines. The study's findings define the exact wiring of the immature virus before it becomes infectious, providing a solid foundation for designing tomorrow's treatments.

SourceMonash University·JournalScience Advances·DateMay 14, 2021

COVID-19 vaccines in patients with cancer

A new study examines the safety of COVID-19 vaccines in patients with cancer, providing insights into potential risks and benefits. The research found that while some cancer treatments may interact with COVID-19 vaccines, the overall risk is low.

SourceJAMA Network·JournalJAMA Oncology·DateMay 13, 2021

'Love thy neighbor, mask up' resonates among white evangelicals

A UCR study found that messages stressing the Christian doctrine of 'love thy neighbor' and aligning mask-wearing with patriotism can effectively persuade white evangelicals to wear masks. The research also suggests that similar messaging could be used for pro-vaccine efforts, particularly targeting Republican-leaning individuals.

SourceUniversity of California - Riverside·JournalProceedings of the National Academy of Sciences·DateMay 13, 2021

CIA's misleading inoculation drive led to vaccine decline in Pakistan

A 2011 CIA-led vaccination campaign in Pakistan led to a significant decline in vaccination rates due to distrust and misinformation. The campaign's misleading tactics created doubt about the integrity of health workers and vaccines, resulting in lower vaccination rates among girls, particularly in districts with high levels of elector...

SourceOxford University Press USA·JournalJournal of the European Economic Association·DateMay 11, 2021

New Strep A human challenge model paves the way to test vaccines against the deadly bacteria

A new Strep A human challenge model has been successfully developed, paving the way to test vaccines against the common deadly bacteria that causes sore throats, scarlet fever and skin sores. The model, which deliberately infected healthy adult volunteers with the bacteria in a controlled environment, was found to be safe and effective.

SourceMurdoch Childrens Research Institute·JournalThe Lancet Microbe·DateMay 9, 2021

More than 25% of infants not getting common childhood vaccinations, study finds

A recent study from the University of Virginia Health System found that more than a quarter of American infants in 2018 had not received all recommended childhood vaccines. Disparities were observed among African-American infants, low-income families, and those with lower education levels. The researchers warn that these gaps can lead ...

SourceUniversity of Virginia Health System·JournalHealth Equity·DateApr 29, 2021

Skipping the second shot could prolong pandemic, study finds

A Cornell-led research survey found that many Americans believe the Moderna and Pfizer-BioNTech vaccines provide weak protection against COVID-19 after a second dose. The study highlights the need for improved guidance on continued public health precautions, such as wearing masks, to combat vaccine attrition and prolong pandemic recovery.

SourceCornell University·JournalNew England Journal of Medicine·DateApr 28, 2021

HPV vaccination in young adults

The study estimates that only about 24% of young adults aged 18 to 21 in the United States have been fully vaccinated against human papillomavirus (HPV). The low vaccination rate is a cause for concern given the significant health risks associated with HPV infection, including cervical cancer and other types of cancer.

SourceJAMA Network·JournalJAMA·DateApr 27, 2021

Story Tip from Johns Hopkins experts on COVID-19

A new study by Johns Hopkins Medicine researchers found that mRNA vaccines for COVID-19 may provide protection against the latest variant strains and even the common cold. The vaccine-induced T cell response was found to be effective in recognizing the spike proteins of both SARS-CoV-2 and three common cold coronaviruses.

SourceJohns Hopkins Medicine·JournalJournal of Clinical Investigation·DateApr 22, 2021